Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review

por Vincken, Nanette L A, Balak, Deepak M W, Knulst, André C, Welsing, Paco M J, van Laar, Jacob M
Publicado 2022

Suppression of IL‐12/IL‐23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon‐γ signaling in dendritic cells: Implications for...

por Vincken, Nanette L. A., Welsing, Paco M. J., Silva‐Cardoso, Sandra C., Bekker, Cornelis P. J., Lopes, Ana P., Olde Nordkamp, Michel, Leijten, Emmerik F. A., Radstake, Timothy R. D. J., Angiolilli, Chiara
Publicado 2022

TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)

por Kleinrensink, Nienke J, Perton, Frank T, Pouw, Juliëtte N, Vincken, Nanette L A, Hartgring, Sarita A Y, Jansen, Mylène P, Arbabi, Saeed, Foppen, Wouter, de Jong, Pim A, Tekstra, Janneke, Leijten, Emmerik F A, Spierings, Julia, Lafeber, Floris P J G, Welsing, Paco M J, Heijstek, Marloes W
Publicado 2022